Truist Financial Forecasts Strong Price Appreciation for American Healthcare REIT (NYSE:AHR) Stock

American Healthcare REIT (NYSE:AHR) had its target price hoisted by Truist Financial from $27.00 to $29.00 in a report issued on Friday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s target price indicates a potential upside of 6.70% from the stock’s current price.

Several other research firms also recently commented on AHR. KeyCorp raised their target price on American Healthcare REIT from $16.00 to $27.00 and gave the stock an “overweight” rating in a research report on Monday, September 16th. Bank of America boosted their target price on shares of American Healthcare REIT from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Tuesday, September 24th. JMP Securities increased their target price on shares of American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, September 20th. Colliers Securities upgraded shares of American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research report on Sunday, October 13th. Finally, Morgan Stanley upped their price objective on shares of American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a research note on Thursday, August 22nd. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $23.25.

American Healthcare REIT Stock Up 3.7 %

Shares of AHR stock opened at $27.18 on Friday. American Healthcare REIT has a 12 month low of $12.63 and a 12 month high of $27.77. The company has a quick ratio of 0.29, a current ratio of 0.29 and a debt-to-equity ratio of 0.60. The firm has a market cap of $3.58 billion and a PE ratio of -56.63. The stock has a 50 day moving average of $25.35 and a 200-day moving average of $19.35.

American Healthcare REIT (NYSE:AHR) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.35). The firm had revenue of $523.81 million during the quarter, compared to the consensus estimate of $474.26 million. American Healthcare REIT had a negative return on equity of 1.96% and a negative net margin of 1.84%. The company’s quarterly revenue was up 12.8% on a year-over-year basis. On average, equities analysts predict that American Healthcare REIT will post 1.41 EPS for the current year.

Institutional Investors Weigh In On American Healthcare REIT

Hedge funds and other institutional investors have recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of American Healthcare REIT by 34.7% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,537 shares of the company’s stock valued at $66,000 after acquiring an additional 654 shares during the period. Kozak & Associates Inc. acquired a new position in American Healthcare REIT during the 3rd quarter valued at about $28,000. Quarry LP bought a new position in shares of American Healthcare REIT in the 3rd quarter valued at about $33,000. Tidemark LLC acquired a new stake in shares of American Healthcare REIT during the 3rd quarter worth approximately $44,000. Finally, Kessler Investment Group LLC bought a new stake in shares of American Healthcare REIT during the third quarter worth approximately $48,000. 16.68% of the stock is owned by institutional investors and hedge funds.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.